A Pilot, Randomized, Single-Blind Study to Assess the Efficacy of the Flexitouch® Lymphedema System in Reducing Lymphedema in Patients Treated for Breast Cancer
PRIMARY OBJECTIVES: I. To quantitatively assess, by circumferential measurements and CT
imaging techniques, the ability of the Flexitouch Lymphedema System to maintain reductions
in limb volume after completion of the reductive phase of complex decongestive therapy in a
population of patients with upper limb lymphedema secondary to the effects of breast cancer
treatment. SECONDARY OBJECTIVES: I. To determine the drainage territory of the lymphatics of
the affected arm and chest using CT and to determine whether these patterns are changed by
treatment with the Flexitouch Lymphedema System/daytime garments versus Flexitouch
Lymphedema System/daytime garments/nighttime bandaging versus standard self-care. OUTLINE:
Patients are randomized to 1 of 3 treatment arms. Arm I: Patients undergo complex
decongestive therapy comprising daily compression garment (sleeve and glove) use, daily
manual lymphatic drainage (self-administered), and nighttime bandaging with low stretch
Comprilan bandages. Arm II: Patients undergo daily compression with garments (sleeve and
glove), nighttime bandaging with low stretch Comprilan bandages, and daily Flexitouch
treatment over 1 hour every evening. Arm III: Patients undergo daily compression with
garments (sleeve and glove) and daily Flexitouch treatment over 1 hour every evening. In
all arms, treatment continues for 3 months.
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Supportive Care
Upper extremity volume measured by circumferential measurements and by CT imaging
At baseline, monthly for 3 months (circumferential measurements only), and end of study
No
Abass Alavi
Principal Investigator
Abramson Cancer Center of the University of Pennsylvania
United States: Institutional Review Board
UPCC 02109
NCT01019512
July 2009
Name | Location |
---|---|
Abramson Cancer Center of the University of Pennsylvania | Philadelphia, Pennsylvania 19104-4283 |